Genetic Technologies Ltd (ASX:GTG)
A$ 0.039 0 (0%) Market Cap: 5.67 Mil Enterprise Value: 5.53 Mil PE Ratio: 9,999.00 PB Ratio: 2.79 GF Score: 0/100

Q3 2022 Genetic Technologies Ltd Business Results Call Transcript

Apr 20, 2022 / 10:00PM GMT
Release Date Price: A$0.4 (-11.11%)
Mike Tonroe
Genetic Technologies Ltd - CFO

Hello, and welcome to our quarter-three business update. I'm Mike Tonroe, Chief Financial Officer, Genetic Technologies. I'm also your host and moderator. Thank you for taking the time to join us today. There will be a presentation with a focus on our quarter-three results ending March 31, 2022, and our plans for the next six months, followed by a Q&A session. (Operator Instructions)

Today, we're pleased to have with us Dr. George Muchnicki, our Non-Executive Director and Medical Adviser, and our CEO, Simon Morriss. Simon was appointed CEO in February 21, 2021, and brings over 20 years of experience within the pharmaceutical, health care, and FMCG industries, having held senior executive positions at Sanofi and Blackmores. Simon has been critical in leading commercialization across the pharmaceutical and healthcare industries and understands the unique pressures and opportunities. He has led companies through strategic adaptation to execution and is driving commercialization strategy and innovation across the business.

I will now hand over

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot